Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hip Fractures | 40 | 2023 | 955 | 11.140 |
Why?
|
Nursing Homes | 50 | 2023 | 1036 | 9.560 |
Why?
|
Homes for the Aged | 13 | 2021 | 260 | 3.870 |
Why?
|
Accidental Falls | 25 | 2023 | 1062 | 3.870 |
Why?
|
Osteoporosis | 15 | 2022 | 1580 | 3.530 |
Why?
|
Bone Density Conservation Agents | 11 | 2022 | 773 | 3.460 |
Why?
|
Frail Elderly | 12 | 2023 | 693 | 2.900 |
Why?
|
Skilled Nursing Facilities | 9 | 2023 | 372 | 2.530 |
Why?
|
Nursing Staff | 3 | 2023 | 129 | 2.290 |
Why?
|
Osteoporotic Fractures | 8 | 2023 | 401 | 2.250 |
Why?
|
Long-Term Care | 8 | 2023 | 607 | 1.850 |
Why?
|
Diphosphonates | 5 | 2020 | 623 | 1.620 |
Why?
|
Medicare | 28 | 2023 | 6566 | 1.540 |
Why?
|
Fractures, Bone | 8 | 2022 | 1947 | 1.320 |
Why?
|
Aged, 80 and over | 49 | 2023 | 57776 | 1.020 |
Why?
|
Hypnotics and Sedatives | 4 | 2019 | 1162 | 0.960 |
Why?
|
Aged | 70 | 2023 | 163280 | 0.900 |
Why?
|
Geriatric Assessment | 6 | 2020 | 1372 | 0.880 |
Why?
|
Dementia | 6 | 2022 | 2518 | 0.860 |
Why?
|
Hospitalization | 9 | 2023 | 10262 | 0.840 |
Why?
|
Activities of Daily Living | 8 | 2023 | 2418 | 0.840 |
Why?
|
Bone Density | 7 | 2023 | 3468 | 0.820 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2046 | 0.800 |
Why?
|
Allied Health Personnel | 2 | 2022 | 162 | 0.770 |
Why?
|
United States | 38 | 2023 | 69872 | 0.770 |
Why?
|
Retrospective Studies | 33 | 2023 | 77449 | 0.660 |
Why?
|
Terminal Care | 2 | 2021 | 1694 | 0.660 |
Why?
|
Vaccination | 6 | 2023 | 3278 | 0.650 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2021 | 1240 | 0.650 |
Why?
|
Hypoglycemia | 2 | 2022 | 861 | 0.640 |
Why?
|
Disabled Persons | 2 | 2018 | 1212 | 0.630 |
Why?
|
Wounds and Injuries | 4 | 2020 | 2400 | 0.620 |
Why?
|
Pelvic Bones | 1 | 2019 | 265 | 0.600 |
Why?
|
Humans | 104 | 2023 | 744343 | 0.580 |
Why?
|
Risk Management | 1 | 2020 | 571 | 0.580 |
Why?
|
Female | 68 | 2023 | 380194 | 0.580 |
Why?
|
Risk Assessment | 13 | 2023 | 23338 | 0.570 |
Why?
|
Drug Utilization Review | 1 | 2017 | 245 | 0.570 |
Why?
|
Male | 61 | 2023 | 350118 | 0.560 |
Why?
|
Health Services for the Aged | 1 | 2018 | 269 | 0.540 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.510 |
Why?
|
Perception | 1 | 2021 | 1198 | 0.500 |
Why?
|
Quality Improvement | 2 | 2021 | 3749 | 0.490 |
Why?
|
Drug Prescriptions | 2 | 2013 | 1637 | 0.470 |
Why?
|
Advance Care Planning | 1 | 2021 | 662 | 0.460 |
Why?
|
Risk Factors | 27 | 2023 | 72290 | 0.450 |
Why?
|
Sulfonylurea Compounds | 3 | 2023 | 204 | 0.440 |
Why?
|
Disease Outbreaks | 2 | 2022 | 1772 | 0.430 |
Why?
|
Child Health Services | 1 | 2018 | 667 | 0.430 |
Why?
|
Cross-Over Studies | 5 | 2017 | 2029 | 0.410 |
Why?
|
Cohort Studies | 15 | 2023 | 40561 | 0.400 |
Why?
|
Checklist | 1 | 2018 | 833 | 0.400 |
Why?
|
Lower Extremity | 1 | 2019 | 1158 | 0.380 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2012 | 135 | 0.380 |
Why?
|
Analgesics | 1 | 2017 | 1040 | 0.380 |
Why?
|
Alendronate | 2 | 2018 | 171 | 0.370 |
Why?
|
Memantine | 1 | 2011 | 100 | 0.370 |
Why?
|
Dopamine Agents | 1 | 2011 | 189 | 0.370 |
Why?
|
Nootropic Agents | 1 | 2011 | 160 | 0.360 |
Why?
|
Health Promotion | 1 | 2022 | 2205 | 0.350 |
Why?
|
Cholinesterase Inhibitors | 1 | 2011 | 238 | 0.350 |
Why?
|
Benzodiazepines | 1 | 2015 | 1101 | 0.340 |
Why?
|
Diuretics | 1 | 2012 | 592 | 0.340 |
Why?
|
Syncope | 1 | 2011 | 429 | 0.320 |
Why?
|
Absorptiometry, Photon | 5 | 2023 | 1725 | 0.310 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1439 | 0.310 |
Why?
|
Teriparatide | 2 | 2021 | 225 | 0.300 |
Why?
|
Pain, Postoperative | 1 | 2017 | 1643 | 0.300 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2021 | 293 | 0.300 |
Why?
|
Influenza, Human | 1 | 2018 | 1479 | 0.300 |
Why?
|
Psychotropic Drugs | 1 | 2013 | 894 | 0.290 |
Why?
|
Subacute Care | 3 | 2023 | 168 | 0.280 |
Why?
|
Intensive Care Units | 1 | 2019 | 3679 | 0.280 |
Why?
|
Incidence | 9 | 2020 | 20947 | 0.270 |
Why?
|
Pandemics | 5 | 2023 | 8388 | 0.260 |
Why?
|
Longitudinal Studies | 4 | 2023 | 13989 | 0.250 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 11725 | 0.250 |
Why?
|
Osteoporosis, Postmenopausal | 2 | 2018 | 386 | 0.250 |
Why?
|
Thiazides | 1 | 2023 | 18 | 0.240 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11727 | 0.240 |
Why?
|
Age Factors | 6 | 2020 | 18370 | 0.230 |
Why?
|
Amlodipine | 1 | 2023 | 83 | 0.230 |
Why?
|
Hypertension | 1 | 2023 | 8480 | 0.230 |
Why?
|
Stroke | 2 | 2023 | 9981 | 0.230 |
Why?
|
Femur Neck | 2 | 2018 | 309 | 0.220 |
Why?
|
Multiple Sclerosis | 1 | 2018 | 3079 | 0.220 |
Why?
|
Vaccines | 2 | 2022 | 822 | 0.220 |
Why?
|
Geriatrics | 3 | 2019 | 396 | 0.220 |
Why?
|
Glipizide | 1 | 2022 | 47 | 0.220 |
Why?
|
Antidepressive Agents | 2 | 2013 | 2838 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Glyburide | 1 | 2022 | 113 | 0.210 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1518 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2017 | 10943 | 0.210 |
Why?
|
Postural Balance | 3 | 2013 | 620 | 0.210 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3057 | 0.200 |
Why?
|
Assisted Living Facilities | 1 | 2021 | 25 | 0.200 |
Why?
|
Medication Adherence | 2 | 2010 | 2063 | 0.200 |
Why?
|
Pharmaceutical Services | 1 | 2023 | 140 | 0.200 |
Why?
|
Pharmacy | 1 | 2023 | 91 | 0.200 |
Why?
|
Pharmacies | 1 | 2023 | 150 | 0.200 |
Why?
|
Age Distribution | 3 | 2017 | 2902 | 0.180 |
Why?
|
Hearing Aids | 1 | 2020 | 55 | 0.180 |
Why?
|
Heart Failure | 1 | 2023 | 10900 | 0.170 |
Why?
|
Sex Factors | 4 | 2019 | 10397 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6538 | 0.170 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 170 | 0.170 |
Why?
|
Resistance Training | 1 | 2021 | 165 | 0.170 |
Why?
|
Pneumonia, Aspiration | 1 | 2019 | 145 | 0.170 |
Why?
|
Comorbidity | 4 | 2019 | 10388 | 0.170 |
Why?
|
Logistic Models | 4 | 2017 | 13408 | 0.160 |
Why?
|
Time Factors | 6 | 2019 | 40075 | 0.160 |
Why?
|
Sex Distribution | 2 | 2017 | 2297 | 0.160 |
Why?
|
Life Expectancy | 2 | 2019 | 1184 | 0.160 |
Why?
|
Medicare Part D | 1 | 2023 | 328 | 0.160 |
Why?
|
Cholinergic Antagonists | 1 | 2019 | 165 | 0.160 |
Why?
|
New Hampshire | 1 | 2018 | 172 | 0.160 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12245 | 0.160 |
Why?
|
Dehydration | 1 | 2019 | 234 | 0.160 |
Why?
|
Odds Ratio | 3 | 2019 | 9849 | 0.160 |
Why?
|
Policy | 1 | 2022 | 508 | 0.160 |
Why?
|
Soft Tissue Injuries | 1 | 2019 | 176 | 0.160 |
Why?
|
Irritable Bowel Syndrome | 1 | 2023 | 445 | 0.160 |
Why?
|
Communication | 3 | 2022 | 3749 | 0.150 |
Why?
|
Calcitonin | 1 | 2018 | 336 | 0.150 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12354 | 0.150 |
Why?
|
Calibration | 1 | 2019 | 816 | 0.140 |
Why?
|
Obesity | 1 | 2019 | 12745 | 0.140 |
Why?
|
Cognition Disorders | 1 | 2011 | 4043 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3022 | 0.140 |
Why?
|
Boston | 3 | 2022 | 9313 | 0.130 |
Why?
|
Follow-Up Studies | 6 | 2017 | 39050 | 0.130 |
Why?
|
New Zealand | 3 | 2021 | 355 | 0.130 |
Why?
|
HIV Infections | 1 | 2021 | 16718 | 0.130 |
Why?
|
Aging | 3 | 2022 | 8664 | 0.130 |
Why?
|
Models, Economic | 1 | 2019 | 713 | 0.130 |
Why?
|
Mobility Limitation | 1 | 2019 | 409 | 0.130 |
Why?
|
Reward | 1 | 2021 | 941 | 0.130 |
Why?
|
Influenza Vaccines | 1 | 2022 | 738 | 0.130 |
Why?
|
Documentation | 1 | 2021 | 871 | 0.120 |
Why?
|
Peer Group | 1 | 2019 | 635 | 0.120 |
Why?
|
Sarcopenia | 1 | 2019 | 368 | 0.120 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 3674 | 0.120 |
Why?
|
Independent Living | 3 | 2019 | 568 | 0.120 |
Why?
|
Biomedical Research | 1 | 2010 | 3309 | 0.120 |
Why?
|
Home Care Services | 2 | 2019 | 606 | 0.120 |
Why?
|
Geography | 1 | 2016 | 669 | 0.120 |
Why?
|
Prognosis | 3 | 2019 | 29063 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4751 | 0.120 |
Why?
|
Renal Insufficiency | 1 | 2019 | 804 | 0.120 |
Why?
|
Health Personnel | 3 | 2022 | 3218 | 0.120 |
Why?
|
Urinary Tract Infections | 1 | 2019 | 788 | 0.110 |
Why?
|
Pneumonia | 2 | 2019 | 2133 | 0.110 |
Why?
|
Moving and Lifting Patients | 1 | 2013 | 18 | 0.110 |
Why?
|
Middle Aged | 10 | 2022 | 213383 | 0.110 |
Why?
|
Case-Control Studies | 2 | 2021 | 21746 | 0.110 |
Why?
|
Hospice Care | 1 | 2019 | 672 | 0.110 |
Why?
|
Massachusetts | 3 | 2017 | 8663 | 0.110 |
Why?
|
Hypoglycemic Agents | 2 | 2023 | 2872 | 0.110 |
Why?
|
Hearing Loss | 1 | 2020 | 765 | 0.110 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2012 | 76 | 0.110 |
Why?
|
Interprofessional Relations | 1 | 2018 | 1011 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 694 | 0.100 |
Why?
|
Motivation | 1 | 2021 | 1971 | 0.100 |
Why?
|
Administration, Oral | 2 | 2023 | 3913 | 0.100 |
Why?
|
Health Status Disparities | 2 | 2020 | 1797 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1076 | 0.100 |
Why?
|
Neoplasms | 1 | 2019 | 21683 | 0.090 |
Why?
|
Acute Disease | 2 | 2012 | 7149 | 0.090 |
Why?
|
Refusal to Participate | 1 | 2010 | 24 | 0.090 |
Why?
|
Testosterone | 1 | 2021 | 2420 | 0.090 |
Why?
|
Survival Rate | 2 | 2018 | 12788 | 0.090 |
Why?
|
Epidemiologic Methods | 2 | 2012 | 1364 | 0.090 |
Why?
|
Length of Stay | 1 | 2023 | 6309 | 0.090 |
Why?
|
Outpatients | 1 | 2017 | 1486 | 0.090 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 634 | 0.080 |
Why?
|
Internet | 1 | 2021 | 3064 | 0.080 |
Why?
|
Recurrence | 3 | 2012 | 8340 | 0.080 |
Why?
|
Pilot Projects | 2 | 2019 | 8324 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4933 | 0.080 |
Why?
|
Rehabilitation Centers | 1 | 2010 | 254 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2616 | 0.080 |
Why?
|
Patient Discharge | 2 | 2023 | 3313 | 0.080 |
Why?
|
Pressure Ulcer | 1 | 2009 | 155 | 0.080 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 469 | 0.080 |
Why?
|
Psychological Tests | 1 | 2010 | 651 | 0.080 |
Why?
|
Hospitals | 1 | 2021 | 3952 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2291 | 0.070 |
Why?
|
Inpatients | 1 | 2018 | 2518 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5391 | 0.070 |
Why?
|
Sepsis | 1 | 2019 | 2593 | 0.070 |
Why?
|
Environment | 1 | 2012 | 1124 | 0.070 |
Why?
|
Databases, Factual | 2 | 2018 | 7729 | 0.070 |
Why?
|
Cognition | 3 | 2021 | 6770 | 0.070 |
Why?
|
Intelligence | 1 | 2010 | 920 | 0.060 |
Why?
|
Cholecalciferol | 1 | 2010 | 537 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3887 | 0.060 |
Why?
|
Prospective Studies | 5 | 2013 | 53288 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5034 | 0.060 |
Why?
|
Dietary Proteins | 1 | 2010 | 963 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3843 | 0.060 |
Why?
|
Muscle Strength | 1 | 2008 | 592 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2951 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2971 | 0.060 |
Why?
|
Propensity Score | 2 | 2021 | 1781 | 0.060 |
Why?
|
Adult | 3 | 2022 | 214055 | 0.060 |
Why?
|
Quality of Life | 2 | 2021 | 12804 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4567 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2022 | 13033 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4931 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19905 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15076 | 0.050 |
Why?
|
Acceleration | 1 | 2022 | 181 | 0.050 |
Why?
|
Vitamins | 1 | 2010 | 1622 | 0.050 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2021 | 88 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6365 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2022 | 3176 | 0.050 |
Why?
|
Prevalence | 1 | 2017 | 15226 | 0.050 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2019 | 32 | 0.050 |
Why?
|
Immunization, Secondary | 1 | 2022 | 340 | 0.050 |
Why?
|
Regression Analysis | 1 | 2010 | 6459 | 0.040 |
Why?
|
Calcium | 2 | 2010 | 5756 | 0.040 |
Why?
|
Anemia | 1 | 2009 | 1506 | 0.040 |
Why?
|
Cause of Death | 1 | 2010 | 3584 | 0.040 |
Why?
|
Vitamin D | 2 | 2010 | 3223 | 0.040 |
Why?
|
Maryland | 1 | 2019 | 276 | 0.040 |
Why?
|
Australia | 1 | 2022 | 1170 | 0.040 |
Why?
|
Internship and Residency | 1 | 2019 | 5788 | 0.040 |
Why?
|
Administration, Topical | 1 | 2021 | 690 | 0.040 |
Why?
|
Constipation | 1 | 2023 | 546 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9687 | 0.040 |
Why?
|
Depression | 2 | 2020 | 7766 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 127 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1769 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7279 | 0.040 |
Why?
|
Mass Screening | 1 | 2013 | 5255 | 0.040 |
Why?
|
Sodium | 1 | 2023 | 1623 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4215 | 0.040 |
Why?
|
Canada | 1 | 2022 | 2065 | 0.040 |
Why?
|
Mortality | 1 | 2008 | 2864 | 0.040 |
Why?
|
Diarrhea | 1 | 2023 | 1348 | 0.030 |
Why?
|
Focus Groups | 1 | 2021 | 1321 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2021 | 63114 | 0.030 |
Why?
|
Indians, North American | 1 | 2019 | 355 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 9959 | 0.030 |
Why?
|
Coronary Disease | 1 | 2009 | 6077 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 857 | 0.030 |
Why?
|
Qualitative Research | 1 | 2022 | 2682 | 0.030 |
Why?
|
Androgens | 1 | 2021 | 1281 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1978 | 0.030 |
Why?
|
Hemorrhage | 1 | 2023 | 3461 | 0.030 |
Why?
|
Patient Participation | 1 | 2021 | 1457 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4397 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12720 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2925 | 0.020 |
Why?
|
Accidents, Home | 1 | 2010 | 75 | 0.020 |
Why?
|
Child | 1 | 2018 | 77709 | 0.020 |
Why?
|
Diet | 2 | 2023 | 7939 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25043 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3647 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3114 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2759 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4286 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4599 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2401 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2009 | 15295 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2012 | 969 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2012 | 2539 | 0.020 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2716 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7785 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 13881 | 0.010 |
Why?
|
Concepts
(274)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_